Result review workflow
MRO coordination matters most when a result needs structured review before the employer receives a final status.
- Lab result handoff
- Review status tracking
- Final reporting support
MRO Coordination
An employer-requested drug or alcohol test must match the employer’s actual order. Before the visit, establish whether the test is DOT-regulated or non-DOT, why it is required, which specimen is ordered and where the result must go.
Have pharmacy or prescriber records available if the MRO asks for them, and respond to contact attempts promptly. A collector documenting that a medicine exists does not finish medical verification. In DOT testing, the MRO applies federal requirements; a state marijuana authorization does not change those rules. Ask the MRO how a finding is verified and the employer how any separate safety concern is handled.
An employer-requested drug or alcohol test must match the employer’s actual order. Before the visit, establish whether the test is DOT-regulated or non-DOT, why it is required, which specimen is ordered and where the result must go. A clinical drug test, a home test and a workplace collection do not automatically satisfy the same requirement. Bring the authorization rather than choosing a panel by its size or name.
A workplace testing program separates collection, laboratory analysis, medical review and the employer’s decision. DOT procedures require the correct custody-and-control process and an authorized laboratory. A medical review officer, or MRO, reviews applicable laboratory findings and legitimate medical explanations. Alcohol testing has its own equipment, technician and confirmation procedures. A negative result does not certify general fitness for duty, and a positive screening result alone does not diagnose a substance-use disorder.
The order may be for pre-employment, random, reasonable-suspicion, post-accident, return-to-duty or follow-up testing. These reasons have different program rules. DOT drug testing uses the substances specified in Part 40. A non-DOT 10-panel, instant screen, hair test or urine ETG alcohol test is not a substitute for the required DOT test. An employer’s non-DOT panel and state requirements must be confirmed separately, including whether cannabis testing is permitted for that role.
Check the authorized site, collection deadline, test reason and billing details with the employer or designated employer representative. Bring photo ID and the order. The collector confirms identity and follows the applicable collection process. Keep the collection receipt and the testing contact details. Respond promptly if the MRO contacts you for information. Ask the employer how it receives the final verified result and when you may start or resume work.
Follow the instructions on the actual order. Provide accurate contact information and have prescription records available for the MRO if requested. Keep medicines in their usual treatment plan unless your prescriber directs a change. Do not use detox products, substitute a specimen or attempt to alter the result. If you have difficulty providing the required specimen or need an accommodation, tell the collector immediately so the proper procedure can be followed.
Do not drive or perform safety-sensitive duties while impaired. After an accident, medical care comes first. The employer must determine the applicable testing trigger and route without delaying necessary treatment. Prescription use can require both result verification and a separate safety assessment. In DOT programs, state permission to use marijuana does not override federal testing rules. Speak with your prescriber about treatment safety; the collection visit is not a place to make an abrupt medication change.
A collection being finished does not mean the result is final. Laboratory work, specimen questions and MRO review may take additional time. DOT employees with a verified positive or other covered violation must follow the applicable substance-abuse-professional and return-to-duty process before resuming safety-sensitive duties. A new self-paid negative test does not erase that requirement. Ask the MRO immediately about any right to test the split specimen and the applicable deadline. Non-DOT disputes follow the actual program and law.
Before arranging an employer collection at Nao, share the written test order. Confirm the exact panel, specimen, DOT status, laboratory route, MRO arrangements, hours, reporting and cost before attending. For a group, mobile or after-hours collection, ask which sites, times and qualified staff are available under your employer’s agreement. DOT oral-fluid collection also requires the current approved laboratory and device pathway; the regulation’s availability does not establish that a particular clinic offers it. TLC drug testing follows TLC’s separate approved-site instructions.
Have pharmacy or prescriber records available if the MRO asks for them, and respond to contact attempts promptly. A collector documenting that a medicine exists does not finish medical verification. In DOT testing, the MRO applies federal requirements; a state marijuana authorization does not change those rules. Ask the MRO how a finding is verified and the employer how any separate safety concern is handled.
Confirm whether the employer-service team can provide the requested services in each worker's state before arranging a nationwide program. Send the job groups, worker locations, governing rules, tests, headcount, deadline and billing/reporting needs to Nao's employer-service team. Request a written state-by-state site and professional roster, actual scope and escalation contacts. A nationwide website claim does not establish an operating clinic, qualified examiner, collection route or contract in each state.
An employer consultation defines the organization's program, sites, authorizations, billing and reports. It is different from an employee's clinical appointment. Employers should send the service list, roles, headcount, locations and timeline to the employer-service team. Employees needing an individual visit should use the relevant patient intake path and employer authorization. Urgent clinical care should not wait for a sales or program-design meeting.
In a DOT program, the MRO reviews applicable laboratory findings and asks for medical information when needed. Keep accurate contact details and prescription records available. Do not assume that telling the collector about a prescription completes verification or establishes fitness for safety-sensitive work.
For DOT testing, the MRO reports the verified result to the designated employer representative, including the applicable result details. For a verified positive, the report identifies the drug or drugs involved. The MRO must not give that representative the laboratory’s numerical drug concentrations. A legitimate prescription can affect verification, but it does not guarantee that no medical information will be shared. DOT rules require separate reporting when medical information indicates disqualification or a significant safety risk in safety-sensitive duties. Ask the MRO to explain the process and any prescribing-clinician contact needed. Non-DOT reporting follows the actual program, authorization and applicable law.
MRO coordination matters most when a result needs structured review before the employer receives a final status.
The employer should understand next steps without trying to manage clinical review logistics.
MRO coordination can sit inside a larger drug testing TPA program.
Confirm which tests require MRO involvement and how final statuses should be delivered.
Keep collection and laboratory steps aligned with the review timeline.
Flag missing information, employee outreach needs, and delayed review steps.
Deliver employer-facing status in the agreed format and channel.
Program administration for employer drug and alcohol testing workflows.
Corporate Health services that fit inside TPA client workflows.
Physicals, labs, testing, vaccines, and injury care for companies.
Role-based screening packages for hiring and compliance programs.
Random pool, selection, collection, and reporting support.
Mobile collection planning for worksites and distributed teams.
Urgent event routing for supervisors and safety teams.
Agency-style program coordination for city, state, transit, and public safety teams.
CBC, CMP, titers, Quantiferon, and employee lab workflows.
PPD, Quantiferon, and TB screening documentation for employers.
Work-status and fitness-for-duty coordination for employers.
Procurement-ready scope, reporting, references, and implementation planning.
Coordinate clinic, collection-site, lab, and mobile routes for multi-state teams.
Coordinate drug-testing and clinical-lab workflows through approved lab paths.
Define after-hours and urgent event routes before incidents happen.
Testing programs for agency, transit, corrections, and public safety teams.